These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 16182210)
61. Deeply dissecting stemness: making sense to non-coding RNAs in stem cells. Uchida S; Gellert P; Braun T Stem Cell Rev Rep; 2012 Mar; 8(1):78-86. PubMed ID: 21706141 [TBL] [Abstract][Full Text] [Related]
62. Quantitative comparison of erythropoietin receptor levels in the epithelial versus endothelial fractions of primary breast tumors. Miller CP; Urban N; Blau CA Anticancer Res; 2011 Apr; 31(4):1189-95. PubMed ID: 21508364 [TBL] [Abstract][Full Text] [Related]
63. Tissue is alive: New technologies are needed to address the problems of protein biomarker pre-analytical variability. Espina V; Mueller C; Edmiston K; Sciro M; Petricoin EF; Liotta LA Proteomics Clin Appl; 2009 Aug; 3(8):874-882. PubMed ID: 20871745 [TBL] [Abstract][Full Text] [Related]
64. Rapid identification of bacterial pathogens using a PCR- and microarray-based assay. Järvinen AK; Laakso S; Piiparinen P; Aittakorpi A; Lindfors M; Huopaniemi L; Piiparinen H; Mäki M BMC Microbiol; 2009 Aug; 9():161. PubMed ID: 19664269 [TBL] [Abstract][Full Text] [Related]
65. Systems medicine: the future of medical genomics and healthcare. Auffray C; Chen Z; Hood L Genome Med; 2009 Jan; 1(1):2. PubMed ID: 19348689 [TBL] [Abstract][Full Text] [Related]
66. Analysis of variance components reveals the contribution of sample processing to transcript variation. van der Veen D; Oliveira JM; van den Berg WA; de Graaff LH Appl Environ Microbiol; 2009 Apr; 75(8):2414-22. PubMed ID: 19233957 [TBL] [Abstract][Full Text] [Related]
68. Elimination of laboratory ozone leads to a dramatic improvement in the reproducibility of microarray gene expression measurements. Branham WS; Melvin CD; Han T; Desai VG; Moland CL; Scully AT; Fuscoe JC BMC Biotechnol; 2007 Feb; 7():8. PubMed ID: 17295919 [TBL] [Abstract][Full Text] [Related]
69. Bioinformatic approach for understanding the heterogeneity of cholangiocytes. Fukushima K; Ueno Y World J Gastroenterol; 2006 Jun; 12(22):3481-6. PubMed ID: 16773705 [TBL] [Abstract][Full Text] [Related]
70. Microarray technology in obstetrics and gynecology: a guide for clinicians. Ward K Am J Obstet Gynecol; 2006 Aug; 195(2):364-72. PubMed ID: 16615920 [TBL] [Abstract][Full Text] [Related]
71. Deciphering cellular states of innate tumor drug responses. Graudens E; Boulanger V; Mollard C; Mariage-Samson R; Barlet X; Grémy G; Couillault C; Lajémi M; Piatier-Tonneau D; Zaborski P; Eveno E; Auffray C; Imbeaud S Genome Biol; 2006; 7(3):R19. PubMed ID: 16542501 [TBL] [Abstract][Full Text] [Related]
72. Design and analysis of two-phase experiments for gene expression microarrays-part I. Jarrett RG; Ruggiero K Biometrics; 2008 Mar; 64(1):208-16. PubMed ID: 17651456 [TBL] [Abstract][Full Text] [Related]
73. 'The 39 steps' in gene expression profiling: critical issues and proposed best practices for microarray experiments. Imbeaud S; Auffray C Drug Discov Today; 2005 Sep; 10(17):1175-82. PubMed ID: 16182210 [TBL] [Abstract][Full Text] [Related]
74. Genes arrayed out for you: the amazing world of microarrays. Chaudhuri JD Med Sci Monit; 2005 Feb; 11(2):RA52-62. PubMed ID: 15668645 [TBL] [Abstract][Full Text] [Related]
75. Microarrays--planning your experiment. Yang JY Methods Mol Med; 2008; 141():71-85. PubMed ID: 18453085 [TBL] [Abstract][Full Text] [Related]
76. Expression profiling of glycosyltransferases and related enzymes using gene microarrays. Hammond JA; Head SR Methods Enzymol; 2006; 416():141-56. PubMed ID: 17113865 [TBL] [Abstract][Full Text] [Related]